Long non-coding RNA in glioma: novel genetic players in temozolomide resistance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long non-coding RNA in glioma: novel genetic players in temozolomide resistance

Published:2023-02-15 Issue:1 Volume:27 Page:19-28
ISSN:1976-8354
Container-title:Animal Cells and Systems
language:en
Short-container-title:Animal Cells and Systems

Author:

Roh Jungwook¹,Im Mijung¹,Kang JiHoon²,Youn BuHyun³,Kim Wanyeon¹⁴

Affiliation:

1. Department of Science Education, Korea National University of Education, Cheongju-si, Republic of Korea

2. Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory, Emory University School of Medicine, Atlanta, GA, USA

3. Department of Biological Sciences, Pusan National University, Busan, Republic of Korea

4. Department of Biology Education, Korea National University of Education, Cheongju-si, Republic of Korea

Publisher

Informa UK Limited

Subject

General Biochemistry, Genetics and Molecular Biology,Animal Science and Zoology

Link

https://www.tandfonline.com/doi/pdf/10.1080/19768354.2023.2175497

Reference96 articles.

1. MEF Promotes Stemness in the Pathogenesis of Gliomas

2. Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry

3. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas

4. Long noncoding RNA MALAT1 knockdown reverses chemoresistance to temozolomide via promoting microRNA-101 in glioblastoma

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glioblastoma stem cell long non-coding RNAs: therapeutic perspectives and opportunities;Frontiers in Genetics;2024-07-02

2. KHDRBS3 facilitates self-renewal and temozolomide resistance of glioblastoma cell lines;2024-06-17

3. HSPA5 and FGFR1 genes in the mesenchymal subtype of glioblastoma can improve a treatment efficacy;Animal Cells and Systems;2024-05-18

4. MCM5 is a Novel Therapeutic Target for Glioblastoma;OncoTargets and Therapy;2024-05

5. Harnessing the potential of nanoengineered siRNAs carriers for target responsive glioma therapy: Recent progress and future opportunities;International Journal of Biological Macromolecules;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3